Replies to post #112 on Pharmasset Inc. (fka VRUS)

[DewDiligence]

this move can't be from [investor] conference news

It isn’t—please see #msg-60676269. Regards, Dew

[surf1944]

6:46AM Pharmasset receives fast track designation from the FDA for the treatment of chronic hepatitis C infection (VRUS) 125.21 : Pharmasset plans to initiate QUANTUM, an interferon-free combination trial with PSI-938 and PSI-7977 in the third quarter of 2011.